Rocket Pharmaceuticals, Inc. ( RCKT) - Stock Earnings
RCKT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -50.3 million USD | — USD |
| 2025Q4 | -42.5 million USD | — USD |
| 2026Q1 | -47.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
RCKT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -245.6 million USD | — USD |
| 2024 | -258.7 million USD | — USD |
| 2025 | -223.1 million USD | — USD |
| 2026 Est. | — | — |
RCKT
Price: $2.80
52 week price:
Earnings Per Share: -1.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 607900
Market Capitalization: 300.3 million